Funding cuts are destabilizing primary healthcare systems and exposing hidden risks in clinical trial supply, from cold chain breakdowns to site readiness gaps.
- When Shipments Stop: Understanding And Managing Customs Delays In Clinical Supply Chains
- U.S. Pharma Tariffs And MFN Become Law After April 2 Update
- 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
- Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think
- From Policy To Practice: Embedding Export Compliance In Clinical Supply
- What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design
- AI And Digital Tools Advance Clinical Trial Supply Chains
- Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials
ON-DEMAND WEBINARS
Join global logistics leaders for an in-depth analysis of the evolving pharmaceutical supply chain, exploring critical issues, emerging trends, and strategies for navigating the complexities of 2024.
Learn about supply strategy optimization while balancing the importance of remaining site-centric in this webinar.
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![gettyimages-871704288-170667a]( "The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies")
The Patient-Centric Clinical Supply Chain For Cell And Gene TherapiesThis article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
![iStock-1224887299-box-logistics-package]( "The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective")
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply PerspectivePerhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
![GettyImages-1254705026 clinical supplies]( "A Supply Chain Management Solution Designed for Clinical Research")
A Supply Chain Management Solution Designed for Clinical ResearchIn this use case, follow along the clinical supplies management journey to learn how GxP Inventory replaces fragmented, spreadsheet-based processes to optimize visibility, traceability, and compliance.
-
![GettyImages-1764818961 warehouse, storage, inventory]( "GxP Inventory Solution Delivers Real-Time Visibility, Operational Efficiency")
GxP Inventory Solution Delivers Real-Time Visibility, Operational EfficiencyExplore how unified forecasting and GxP-level inventory control can streamline your clinical supply chain, reduce risk, and strengthen oversight across every trial you run.
-
![Sales Advice Data Analytics]( "Complex Randomization Delivered Successfully")
Complex Randomization Delivered SuccessfullyLearn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
![Doctor Clinical Trial]( "IRT? RTSM? What's The Difference?")
IRT? RTSM? What's The Difference?What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
![GettyImages-1693748594 phone]( "RTSM: Randomization And Cohort Management, IP Inventory Management")
RTSM: Randomization And Cohort Management, IP Inventory ManagementSignant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
![GettyImages-980809416 clinical supply]( "Common RTSM/IRT AN Medication Pooling Questions Answered")
Common RTSM/IRT AN Medication Pooling Questions AnsweredWhether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
![GettyImages-1156884561-fill-finish]( "Key Considerations For Selecting Flexible Fillers")
Key Considerations For Selecting Flexible FillersFlexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
